Xie X, Yu M, Wu Q
General Hospital of Shenyang Unit of People's Liberation Army.
Zhonghua Wai Ke Za Zhi. 1995 Apr;33(4):229-31.
In order to study the relationships between the mutant p53 gene and human bladder cancer, the authors used in situ hybridization to detect 30 of bladder cancer and 4 of normal bladder samples. The results showed that p53 gene positive rate of mRNA was 23.3% in cancer patient, and all negative in normal-bladder. The positive rate was significantly different in pathological grading and clinical stages of carcinoma (P < 0.05). It suggests that the mutant p53 gene participats in transformation of carcinoma and may be used as a tumor marker for determinating invasiveness and prognosis of bladder carcinoma.
为了研究突变型p53基因与人类膀胱癌之间的关系,作者采用原位杂交技术检测了30例膀胱癌组织和4例正常膀胱组织样本。结果显示,癌患者中p53基因mRNA阳性率为23.3%,正常膀胱组织均为阴性。该阳性率在癌的病理分级和临床分期中存在显著差异(P<0.05)。这表明突变型p53基因参与了癌的转变,可能作为判断膀胱癌侵袭性和预后的肿瘤标志物。